The investment-grade notes were issued in four tranches

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €3.5 billion aggregate principal amount of notes by Medtronic Global Holdings S.C.A. Medtronic Global Holdings S.C.A. issued €500 million aggregate principal amount of 2.625% senior notes due 2025, €1 billion aggregate principal amount of 3.000% senior notes due 2028, €1 billion aggregate principal amount of 3.125% senior notes due 2031 and €1 billion aggregate principal amount of 3.375% senior notes due 2050, fully and unconditionally guaranteed by Medtronic plc and Medtronic, Inc. Medtronic plc is the parent company of Medtronic Global Holdings S.C.A. and Medtronic Global Holdings S.C.A. is an indirect parent company of Medtronic, Inc.

Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 95,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries.

The Davis Polk corporate team included partner Deanna L. Kirkpatrick, counsel Jeffrey S. Ramsay and associates Prince Kudolo, Courtney Y. Sohn and Rachel Jang. Partner Patrick E. Sigmon and associates Eitan Ulmer and Kendra Simpson provided tax advice. The intellectual property and technology transactions team included partner David R. Bauer and associate Adrian Rabin. All members of the Davis Polk team are based in the New York office.